搜索
ss
ss
关于普米斯
About Us
z350

Andy Tsun(Director)

Current VP of Biotheus. Ph.D., University of Oxford, UK, post-doctorate at the Shanghai Pasteur Institute of the Chinese Academy of Sciences. Served as Associate Professor at the Shanghai Pasteur Institute of the Chinese Academy of Sciences and lead three National Natural Science Foundation projects as SME. As the core scientist of the joint research project between Chinese Academy of Sciences and international pharmaceutical companies, he has published nearly 35 papers in international academic journals. Andy was once the Director New Drug Research of Innovent Biologics, responsible for the functional biology research of new tumor immunotherapy antibody drugs. During this period, as the deputy project leader, he participated and led the whole process from drug discovery, cell line development to clinical trial application of the anti-tumor antibody drug PD-1 antibody-Sintilimab. Andy also led the discovery and development of multiple therapeutic antibodies such as OX40, CD47 and LAG-3.
z350
Product description
Parameters

Current VP of Biotheus. Ph.D., University of Oxford, UK, post-doctorate at the Shanghai Pasteur Institute of the Chinese Academy of Sciences. Served as Associate Professor at the Shanghai Pasteur Institute of the Chinese Academy of Sciences and lead three National Natural Science Foundation projects as SME. As the core scientist of the joint research project between Chinese Academy of Sciences and international pharmaceutical companies, he has published nearly 35 papers in international academic journals. Andy was once the Director New Drug Research of Innovent Biologics, responsible for the functional biology research of new tumor immunotherapy antibody drugs. During this period, as the deputy project leader, he participated and led the whole process from drug discovery, cell line development to clinical trial application of the anti-tumor antibody drug PD-1 antibody-Sintilimab. Andy also led the discovery and development of multiple therapeutic antibodies such as OX40, CD47 and LAG-3.

Keyword:
董事
抗体
作为
公司
上海
领导
巴斯德
曾任
新药
药物
Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table
Next
There is currently no content to display
Please add data record on website background.

Copyright: © 2021 Biotheus, Inc.     粤ICP备2021122492号      Powered by www.300.cn